Clinical Trial Update: A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Cetuximab and Methotrexate combination in squamous cell carcinoma of the head and neck (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Cetuximab (cetuximab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1, Phase 2 | Status: UNKNOWN